Scholars Central

Research articlePublished 2015

Safety and Effectiveness of Propofol Sedation during Endoscopic Retrograde Cholangiopancreatography

Authors: Minami T, Sasaki T, Serikawa M, Ishigaki T, Ishii Y, Mouri T, Yoshimi S, Shimizu A, Tsuboi T, Kurihara K, Tasugawa Y, Miyaki E, Nakamura R, Chayama K

Anesthesia & Clinical Research

Volume 6 · Issue 3 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objectives: Evidence of the safety and usefulness of propofol sedation during endoscopic retrograde cholangiopancreatography is presently insufficient; our study aimed to add such information. Methods: Patients were sedated using propofol or midazolam during endoscopic retrograde cholangiopancreatography. The safety and utility of the sedatives were compared. Safety parameters included examination cancellation rate, circulatory depression, and respiratory depression. Utility parameters included pain level, sedation tolerability rate, and bispectral index sedation level. Results: The propofol and midazolam groups contained 30 and 27 patients, respectively. No patient had an examination cancelled for sedation-related reasons. Blood pressure reduction (mmHg) was 24.1 ± 19.7 and 28.1 ± 20.7 in the midazolam and propofol groups, respectively, showing no significant difference. Pulse rate decrease (beats/min) was 2.4 ± 5.6 and 1.7 ± 4.5 in the propofol and midazolam groups, respectively, with no significant difference. Arterial carbon dioxide tension (mmHg) increased by 10.2 ± 6.5 and 10.8 ± 7.2 in the propofol and midazolam groups, respectively, showing no significant difference. Arterial oxygen saturation reduced by 2.9 ± 2.2% and 1.5±1.7% in the midazolam and propofol groups, respectively. The percentage of patients with <92% oxygen saturation showed no significant difference. The pain level was 0.9 ± 1.3 in the propofol group, and significantly lower than 2.4 ± 2.7 in the midazolam group. The sedation tolerability rate was 93.3% for propofol, and significantly higher than 74.1% for midazolam. The bispectral index (mean value/minimum value) was 75.1 ± 10.6/63.9 ± 12.1 for propofol, and significantly lower than 80.5 ± 4.2/72.0 ± 5.0 for midazolam. Conclusions: Propofol sedation had similar safety and superior efficacy to midazolam. Stepwise adjustments of propofol dosage likely result in safer sedation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Anesthesia & Clinical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnesthesia & Clinical Research
  • SubjectAnaesthesia & Pain
  • BylineArticles whose byline prints “Minami T”
  • BylineArticles whose byline prints “Sasaki T”
  • BylineArticles whose byline prints “Serikawa M”
  • BylineArticles whose byline prints “Ishigaki T”
  • BylineArticles whose byline prints “Ishii Y”
  • BylineArticles whose byline prints “Mouri T”
  • BylineArticles whose byline prints “Yoshimi S”
  • BylineArticles whose byline prints “Shimizu A”